Cargando…
Effect of Inhaled β(2)-Agonist on Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease
The fractional exhaled nitric oxide measured at an expiratory flow of 50mL/s (FE(NO)50) is a marker of airway inflammation, and high levels are associated with greater response to steroid treatment. In asthma, FE(NO)50 increases with bronchodilation and decreases with bronchoconstriction, the latter...
Autores principales: | Amer, Mostafa, Cowan, Jan, Gray, Andrew, Brockway, Ben, Dummer, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892672/ https://www.ncbi.nlm.nih.gov/pubmed/27258087 http://dx.doi.org/10.1371/journal.pone.0157019 |
Ejemplares similares
-
Inhaled and exhaled nitric oxide
por: Thébaud, B., et al.
Publicado: (1999) -
Exhaled nitric oxide in stable chronic obstructive pulmonary disease
por: Beg, Mohammed F. S., et al.
Publicado: (2009) -
Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary
Disease: Clinical Implications of the Use of Inhaled Corticosteroids
por: Jo, Yong Suk, et al.
Publicado: (2020) -
Clinical Features of Chronic Obstructive Pulmonary Disease with High Fractional Exhaled Nitric Oxide
por: Ahn, Seong, et al.
Publicado: (2020) -
Exhaled Nitric Oxide is Not a Biomarker for Pulmonary Tuberculosis
por: López, José W., et al.
Publicado: (2018)